Results 81 to 90 of about 38,460 (214)

Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis

open access: yesNew England Journal of Medicine, 2017
A. Banerji   +27 more
semanticscholar   +1 more source

Berotralstat in hereditary angioedema due to C1 inhibitor deficiency: first real-world evidence from a Canadian center

open access: yesFrontiers in Immunology
BackgroundHereditary angioedema due to C1 inhibitor deficiency is a rare genetic condition that causes recurrent swelling with consequent functional impairment and decreased quality of life. Long-term prophylaxis (LTP) to prevent angioedema episodes is a
Cindy Srinivasan   +2 more
doaj   +1 more source

Editorial: Proceedings of KININ2018CLE, Cleveland, Ohio, June 18-20, 2018: A Compendium of the Presentations

open access: yesFrontiers in Medicine, 2019
Alvin H. Schmaier   +4 more
doaj   +1 more source

Unleashing the therapeutic potential of human kallikrein-related serine proteases

open access: yesNature reviews. Drug discovery, 2015
I. Prassas   +3 more
semanticscholar   +1 more source

kallikrein

open access: yes
Citation: 'kallikrein' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.13356 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms.
openaire   +1 more source

Structural and functional characterization of human kallistatin. [PDF]

open access: yesBiochem Biophys Rep
Pham STD   +8 more
europepmc   +1 more source

<i>Ex vivo</i> bradykinin as a functional biomarker for angioedema with normal C1-inhibitor. [PDF]

open access: yesJ Allergy Clin Immunol Glob
Chen J   +6 more
europepmc   +1 more source

Kidney kallikrein-1 contributes to cleavage of γ-ENaC in vivo. [PDF]

open access: yesAm J Physiol Renal Physiol
Curry JN   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy